Accesso libero

Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms

Snežana Đorđević

Snežana Đorđević

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Đorđević, Snežana
, 
Nataša Perković Vukčević

Nataša Perković Vukčević

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Vukčević, Nataša Perković
, 
Marko Antunović

Marko Antunović

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Antunović, Marko
, 
Vesna Kilibarda

Vesna Kilibarda

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Kilibarda, Vesna
, 
Gordana Vuković Ercegović

Gordana Vuković Ercegović

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Ercegović, Gordana Vuković
, 
Jasmina Jović Stošić

Jasmina Jović Stošić

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Stošić, Jasmina Jović
 e 
Slavica Vučinić

Slavica Vučinić

University of Defence, Military Medical Academy Medical Faculty, National Poison Control CentreBelgrade, Serbia
Cerca questo autore su
Sciendo|Google Scholar
Vučinić, Slavica
  
07 lug 2022
Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Original article
Pubblicato online: 07 lug 2022
Pagine: 126 - 130
Ricevuto: 01 feb 2022
Accettato: 01 mag 2022
DOI: https://doi.org/10.2478/aiht-2022-73-3635
Parole chiave
© 2022 Snežana Đorđević, Nataša Perković Vukčević, Marko Antunović, Vesna Kilibarda, Gordana Vuković Ercegović, Jasmina Jović Stošić, and Slavica Vučinić, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Total number of patients admitted to NPCC in 2017/18
Total number of patients admitted to NPCC in 2017/18

Figure 2

Olanzapine serum concentrations in patient 2 over four days of hospitalisation after the second admission for overdosing three months apart
Olanzapine serum concentrations in patient 2 over four days of hospitalisation after the second admission for overdosing three months apart

Figure 3

Olanzapine serum concentrations in overdosed patient 4 over six days with fatal outcome
Olanzapine serum concentrations in overdosed patient 4 over six days with fatal outcome

Figure 4

Olanzapine serum concentrations in a 50-year-old patient who ingested 120 mg of olanzapine
Olanzapine serum concentrations in a 50-year-old patient who ingested 120 mg of olanzapine

Figure 5

Creatinine kinase levels (IU/L) in hospitalised male (a) and female (b) patients with lines representing threshold values (300 IU/L for men and 200 IU/L for women)
Creatinine kinase levels (IU/L) in hospitalised male (a) and female (b) patients with lines representing threshold values (300 IU/L for men and 200 IU/L for women)

Patients with serum olanzapine concentrations above the lethal threshold of 1 mg/L

Patient Sex Age Ingested dose Time from ingestion to blood collection Concentration (mg/L) PSS
1 male 26 about 150 mg 6 h 3.40 2
2 female 26 1680 mg 5 h 2.44 3
unknown >12 h 1.75 3
3 female 59 560 mg 3 h 1.53* 4
4 male 43 unknown >24 h 1.18 3

Serum concentrations of co-ingested drugs (mg/L) during the hospitalisation

Day Olanzapine (mg/L) Clozapine (mg/L) Norclozapine (mg/L) Lamotrigine (mg/L) Midazolam (mg/L) Zolpidem (mg/L)
1 0.28 0.29 0.02 3.62 0.21 0.83
2 0.42 0.22 0.03 2.19 <LOD 0.19
3 0.59 0.49 <LOD 2.74 <LOD 0.15
4 1.53 0.68 <LOD 3.5 <LOD 0.14
5 0.31 0.7 <LOD < 1.0 <LOD 0.06
Lingue:
Inglese, Croatian, Slovenian
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Scienze medicali di base, altro
Feed RSS della rivista